Skip to main content
Caplight Logo









OrthoSon

OrthoSon

Private
OxfordHealthcare & Life Scienceshttps://www.orthoson.com/

Last Round

Series B

Sep 15, 2023

Total Funding Raised

$14.69M

Company Overview

OrthoSon is a medical technology company that develops minimally invasive, ultrasound-based treatments and bio-structural implants for degenerative disc disease and chronic back pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical devicedegenerative disc diseasemedtechhydrogel implanttherapeutic ultrasoundminimally invasive surgeryback pain treatmentbiomaterialsspinal fusion alternativeorthopedicsspine carespine surgeryFDA breakthrough devicebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrthoSon Comparables

Compare OrthoSon with similar companies based on industry and business-model similarity.

OrthoSon comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ReGelTec, Inc.
90%
VIVEX Biologics
80%
DiscGenics
78%

OrthoSon Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 15, 2023
Series AMay 3, 2022
SeedNov 1, 2019

Key People

Founding team and executive leadership

Constantin Coussios OBE FREng FMedSci

Founder & Chief Technology Officer

Founding Team

OrthoSon Investors

Notable investors and investment history

OrthoSon investors
InvestorRounds
OTIFSeed
Yonghua CapitalSeries A
Oxford Technology and Innovations EIS FundSeries A, Seed
Big Pi VenturesSeries A
Oxford Investment ConsultantsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2022

    Raised $11M from Yonghua Capital, Big Pi Ventures, and Oxford Technology.

OrthoSon Filings

Explore SEC and related filing metadata, where available.

OrthoSon filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OrthoSon's valuation, stock price, and market status.

Is OrthoSon a public or private company?

OrthoSon is a private company.

What is the current stock price of OrthoSon?

OrthoSon is a private company with no public stock price. No recent secondary market data is available.

How much is OrthoSon worth (valuation)?

Valuation information for OrthoSon is not publicly available.

Can I buy OrthoSon stock?

OrthoSon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OrthoSon's last funding round?

OrthoSon's most recent funding round was Series B on September 15, 2023.

Who are the main investors in OrthoSon?

Key investors in OrthoSon include Oxford Technology and Innovations EIS Fund.

Will OrthoSon IPO soon?

No public IPO plans have been announced for OrthoSon.

How can I track OrthoSon secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OrthoSon's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOxford
Employee Range16
Year Founded2015
Last FundingSep 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?